Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer
01 avr. 2022 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Michael Fillion has joined the Company as its Chief Operating Officer. “We are pleased to...
Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients
22 mars 2022 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), the pioneer and leader of fully personalized knee and hip replacement systems, today announced a strategic...
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
14 mars 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Denise Pedulla has joined the Company as its Chief Legal Officer and Corporate Secretary. “We...
Gary Fischetti nominated to join Conformis’ Board of Directors
11 mars 2022 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Gary P. Fischetti has been nominated to stand for election to the Company’s Board of...
Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results
02 mars 2022 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Suspends All Distribution Operations and Business Development in Russia
02 mars 2022 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced that it was suspending all distribution operations to Russia and any Russian-based entities for its...
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
28 févr. 2022 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), the pioneer and leader of fully personalized orthopedic medical devices, today announced results of a published...
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel
24 févr. 2022 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, today announced...
Conformis, Inc. to Participate in Upcoming Investor Conferences
18 févr. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
20 janv. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial...